- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02828436
Spinal Cord Stimulation to Treat Hypertension
August 25, 2020 updated by: University of Minnesota
A Pilot Study to Assess Spinal Cord Stimulation To Inhibit Afferent Feedback During Exercise in Hypertension
To investigate the exercise blood pressure response during a lower-extremity dynamic exercise in postmenopausal women with hypertension and to determine if lumbar epidural spinal cord stimulation reduces blood pressure during exercise in postmenopausal women and men with hypertension.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single center study conducted at the University of Minnesota, enrolling up to forty subjects (30 men and 30 post-menopausal women).
Subjects will be a assigned to one of the two study arms, (Dynamic Exercise or Spinal Cord Stimulation) and then crossover to the other arm after the initial assignment is complete.
However is the screening MRI determines the subject is not a candidate for spinal cord stimulation, then they will be assigned to the Dynamic Exercise arm only.
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and post-menopausal women between the ages of 40-90 years old
- Hypertension (defined as BP ≥ 140/90), diagnosed by a physician
- Ability of the patient to provide consent
Exclusion Criteria:
- History of cardiopulmonary disorders other than hypertension, as determined on the medical evaluation questionnaire.
- History of dangerous arrhythmias (arrhythmias requiring treatment or requiring physician supervision)
Currently taking specific anti-hypertensive medications that may affect the exercise pressor response or influence the effect of spinal cord stimulation.
Please contact study staff for information regarding your eligibility.
- History of spinal fusion or laminectomy at L3 or above
- Current prescription opioid usage
- Contraindication to MRI
- At physician discretion which will be documented on the case report form.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Spinal Cord Stimulation
Boston Scientific Precision Spectra System
|
Spinal Cord Stimulation
|
Other: Exercise Intervention
If subject cannot tolerate Spinal Cord stimulation they will be assigned this arm
|
Standard Exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Exercise Pressor Reflex From Baseline
Time Frame: 2 years
|
Change in blood pressure during exercise.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Manda Keller-Ross, PhD, DPT, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2017
Primary Completion (Actual)
September 1, 2019
Study Completion (Actual)
September 1, 2019
Study Registration Dates
First Submitted
June 15, 2016
First Submitted That Met QC Criteria
July 6, 2016
First Posted (Estimate)
July 11, 2016
Study Record Updates
Last Update Posted (Actual)
September 16, 2020
Last Update Submitted That Met QC Criteria
August 25, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1604M86961
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Precision Spectra System
-
Poitiers University HospitalCompleted
-
Boston Scientific CorporationCompletedChronic PainUnited States
-
Boston Scientific CorporationCompleted
-
Boston Scientific CorporationTerminatedChronic Neuropathic Pain in the Low Back and LegsUnited Kingdom
-
Boston Scientific CorporationTerminated
-
Boston Scientific CorporationCompletedBack Pain | Chronic PainUnited States
-
Boston Scientific CorporationCompletedPain | Back Pain | Chronic Pain | Pain, Intractable | Failed Back Surgery SyndromeUnited States
-
Endofotonics Pte LtdZhongshan Hospital Xiamen UniversityRecruitingGastric Cancer | Gastric Precancerous LesionChina
-
Terumo BCTCompletedGranulocyte/ Polymorphonuclear CellsUnited States
-
Terumo BCTCompletedThrombocytosis | Thrombocythemia | Myeloproliferative DiseaseDenmark, Hungary